bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.11.18.689108

NFAT5 Confers Differential Expression in Innate Immune Cells vs. Renal Epithelial Cells in the Face of Osmotic Stress

Abstract

The kidney develops an osmotic gradient, up to 1300 mOsm, to drive the reabsorption of water. However, this creates a harsh environment for renal epithelial and immune cells. These cells need to develop a survival mechanism to prevent against osmotic stress and maintain homeostasis in this harsh environment. Nuclear Factor of Activated T Cells 5 (NFAT5, also known as Tonicity-Responsive Enhancer-Binding Protein factor or TonEBP) is a master transcription factor that responds to changes in osmolarity, regulating the transcription of genes that control the intracellular accumulation of osmolytes. Studies suggest that NFAT5 may be responsible for cell survival in this environment. Both epithelial and immune cells play a role in pro-inflammatory responses and disease progression. Additionally, NFAT5 may also play divergent roles, promoting the expression of pro-inflammatory genes in immune cells, and anti-inflammatory genes in epithelial cells. We hypothesized that NFAT5 expression was protective in epithelial cells, while stimulation in immune cells may be proinflammatory. We performed survival assays to assess an NFAT5-dependent role in hyperosmolar environments. We also assessed gene expression and identified targets that may be responsible for cell survival, as well as demonstrating divergent mechanisms in epithelial and immune cells. In conclusion, we found NFAT5 is critical to cell survival in hyperosmolar environments and identified transcripts such as bgt1, aqp1 and akr1b3 that may explain the difference in survival. We also observed a difference in expression between epithelial and raw cells, including the same targets thought to protect against hyperosmotic stress in IMCD3 cells that showed differential regulation by NFAT5. These data suggest a divergent NFAT5 mechanism in two cell types present in the kidney.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kraus, X., Nnah, F., Cowley, C., Araos, P., Wynne, B. M.. 2025-11-18. NFAT5 Confers Differential Expression in Innate Immune Cells vs. Renal Epithelial Cells in the Face of Osmotic Stress. https://doi.org/10.1101/2025.11.18.689108

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Nucleosome Core Allostery Governs Chromatin Recognition and Cell Fate

Nucleosomes regulate chromatin folding, accessibility, and factor recruitment. Current models primarily attribute these functions to histone tail modifications, while the core is largely viewed as a structural scaffold. Yet subtle changes within the nucleosome core can produce profound functional consequences, and the mechanisms underlying these effects remain unclear. Here, we describe nucleosome core allostery as a fundamental principle of chromatin regulation that amplifies the impact of minimal nucleosome variations. Leveraging natural differences between H2A.Z variants, we show that the nucleosome core encodes distinct conformational dynamics that propagate allosterically, thereby controlling nucleosome accessibility and recognition by chromatin factors. As a result, a single buried amino acid substitution alone is sufficient to reprogram nucleosome dynamics and bias cell identity. Our findings establish the nucleosome core as an allosteric regulatory module and provide a generalizable framework for how subtle variation within nucleosomes is amplified into diverse biological outcomes in development and disease.

cell biology↗

SOX4 Reprograms Adipose Stromal Cells into a Cancer-Associated Fibroblast-like State to Drive Metabolic Disease

Pathogenic adipose tissue remodeling promotes metabolic disease in obesity, but the mechanisms that establish this unhealthy tissue state remain poorly understood. Here, we show that obesity drives SOX4-dependent reprogramming of mesenchymal stromal cells (MSCs) into cancer-associated fibroblast-like (CAF-like) cells that promote adipose tissue dysfunction. TGF{beta} signaling is elevated in obesity and activates SOX4 in mouse and human MSCs, inducing their conversion to a CAF-like state. In mice, MSC-specific SOX4 activation induces the CAF-like program and exacerbates adipose tissue inflammation and glucose intolerance, whereas Sox4 deletion attenuates inflammation and improves glucose homeostasis during obesity. We further identify the growth factor Midkine (MDK) as a SOX4-regulated paracrine effector produced by CAF-like cells. MDK inhibition in obese mice reduces adipose tissue inflammation and improves metabolic function. Together, these findings define a TGF{beta}-SOX4-MDK stromal signaling axis that drives pathological adipose tissue remodeling in obesity and highlight this pathway as a potential therapeutic target for improving metabolic health.

cell biology↗

PDLIM5 Modulates YAP1 Localisation and Fibrogenic Gene Expression in Hepatic Stellate Cells

Hepatic stellate cells (HSCs) are the key cellular drivers of liver fibrosis. During liver injury and chronic inflammation HSCs adopt an activated phenotype and secrete fibrotic extracellular matrix (ECM) components such as collagen 1. Mechanical cues derived from the fibrotic ECM drive and support the activation of HSCs, via mechanisms that involve integrins and the mechano-sensitive transcriptional regulator YAP1. It is not yet well understood how external mechanical cues are translated into a molecular response that alters YAP1 nuclear shuttling. There is evidence that suggests the PDZ and LIM domain protein (PDLIM) 5 can regulate YAP1 shuttling in human epithelial cells. We therefore investigated whether PDLIM5 is expressed in HSCs and contributes to YAP1 associated HSC mechano-activation. PDLIM5 protein was detected in HSCs in fibrotic human and mouse liver. PDLIM5 transcript and protein were expressed by primary human and mouse HSCs and by the immortalised HSC LX-2 cell line. PDLIM5 localised with actin stress fibres suggesting a role in HSC adhesion. Co-immunoprecipitation and proximity ligation in LX-2 cells support an association between PDLIM5 and YAP1. We used pharmacological (paclitaxel) and genetic (siRNA and CRISPRi) approaches to inhibit PDLIM5 in HSCs. Inhibiting PDLIM5 reduced YAP1 nuclear localisation and fibrotic gene (COL1A1, ACTA2) expression in LX-2 cells. Overall, these data support a role for PDLIM5 in regulating YAP1 localisation and fibrogenic gene expression in HSCs.

cell biology↗